|
|
FDA publishes guidance on marketed unapproved drugs
The FDA has published a guidance on Marketed Unapproved Drugs—Compliance Policy Guide, which describes the agency’s enforcement priorities with regard to products that lack regulatory approval or that are not marketed in accordance with the over-the-counter drug review. More... |
|
EMA offers positive opinion on new drugs
The latest meeting of the EMA’s Committee for Medicinal Products for Human Use has concluded with more than 15 positive opinions for new and generic drugs and the adoption of key concept papers. More... |
|
Concern over pharma-contaminated water
The public has been concerned about pharmaceuticals in the water supply for some time and new research from French scientists may add to the alarm after diuretics and anti-inflammatory agents were identified in a river. More... |
|
New FDA guidance on user fee waivers, reductions and refunds
The FDA has issued a guidance titled User Fee Waivers, Reductions and Refunds for Drug and Biological Products that outlines the agency’s policies for issuing waivers, refunds or reductions in prescription drug user fees.
More... |
|
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More... |
|
Event Profile |
QP Association
Get an update on all developments relevant to European QPs and benefit from the opportunity to network with regulators and industry experts at the 6th QP Forum in Budapest, Hungary, from 1-2 December.
Read more
|
|
BioManufacturing World China 2011
Nov 30 Dec 1 2011
Shanghai, China
BioManufacturing World China, co-located under Bio World China 2011 aims to bring together international and China biopharmaceutical manufacturing leaders, technical and operational heads and technology providers and other stakeholders to come together to establish and renew partnerships to help develop new products, acquire new process technologies, and establish new contract manufacturing relationships.
Read more |